医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

广告
第一作者: Sunny,Malhotra
第一单位: Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
作者单位: Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. [1] Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.;Institute of Experimental Immunology, Laboratory of Neuroinflammation, University of Zurich, Zurich, Switzerland. [2] Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.;Faculty of Biology, University of Freiburg, Freiburg, Germany. [3] Biomedical Research Institute of Murcia (IMIB-Arrixaca), University Clinical Hospital Virgen de la Arrixaca, Murcia, Spain. [4] Renal Physiopathology Group, Institut de Recerca Vall d'Hebron (VHIR) - CIBBIM Nanomedicine, Barcelona, Spain. [5] Grupo de Neuroinmuno-Reparación, Hospital Nacional de Parapléjicos-SESCAM, Toledo, Spain. [6] Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), Madrid, Spain. [7] Genomic Systems, Valencia, Spain. [8] Neuroimmunology and Neuroinflammation Group, Instituto de Investigación Biomédica de Málaga-IBIMA, UGC Neurociencias, Hospital Regional Universitario de Málaga, Málaga, Spain. [9] Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra", Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain. [10] Universidad del País Vasco (UPV/EHU), Leioa, Spain.;IKERBASQUE, Basque Foundation for Science, Bilbao, Spain. [11] Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain. [12] Department of Neurology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. [13] Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Barcelona, Spain.;Statistics and Bioinformatics Unit, Vall d'Hebron Institut de Recerca, Barcelona, Spain. [14] School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia. [15] Institute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.;Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.;Center for NeuroModulation (NeuroModul), Faculty of Medicine, University of Freiburg, Freiburg, Germany. [16] Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.;Center for Multiple Sclerosis, St, Michael's Hospital, University of Toronto, Toronto, ON, Canada. [17]
DOI 10.1093/brain/awaa084
PMID 32282893
发布时间 2022-01-05
提交
  • 浏览22
Brain : a journal of neurology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷